Fundraising Fox

May Han

Investor

Partner at Cure Ventures

Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Partner with over 20 years in drug discovery and development across small molecules, biologics and cell therapies, with deep expertise in oncology and metabolic diseases. Previously held leadership roles at Novartis, AVEO and Millennium Pharmaceuticals.

LinkedIn ↗

Experience

  1. Cure VenturesPartnercurrent2021 — presentGreater Boston
  2. NovartisDirector, Project Management2013 — 2021
  3. AVEO OncologyProgram Leader2012 — 2013
  4. AVEO OncologyDirector of Preclinical Development2003 — 2012
  5. Millennium Pharmaceuticals Inc.Scientist II2000 — 2003
  6. Yale UniversityPostdoc1997 — 2000
  7. Rockefeller UniversityGraduate student and Postdoc1993 — 1997

Education

  1. Yale UniversityPh.D., Biophysics and Biochemistry1990 — 1996
  2. Peking UniversityBS, Biochemistry1986 — 1990

Same school

Also attended Yale University493

Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorZheela QaiserInvestor at Index VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)TinaInvestments & Portfolio Services Team Member at Clear Ventures

+ 487 more

Also attended Peking University107

Erica WuInvestment Director at Intel CapitalGiuseppe IademarcoHead of Global Partnership at P101 VenturesLucy BradyHead of Product at Giant Ventures Global LlpLuke TangManaging Partner at G Vision CapitalRaaj RayatPrincipal at AirTree VenturesKathy WangInvestor at Inception Studio Capital

+ 101 more

Shared employers

Also worked at Novartis105

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 99 more

Also worked at AVEO Oncology2

Jeno GyurisPartner at Cure VenturesRaju KucherlapatiVenture Partner at Catalio Capital Management, LP

Also worked at Yale University71

Ann Miura-KoCo-founding Partner at FloodgateStacey HeroInvestor at Third Rock VenturesVivek GopalanInvestment Team at 8VCSallie KimInvestor at 8VCPaul CoyerVenture Partner at IronGate Capital AdvisorsMax WebsterFounder at Hivemind Ventures, Llc

+ 65 more

Also worked at Rockefeller University14

Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Hani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersMira ChaurushiyaManaging Director at Westlake Village BioPartnersEli CasdinChief Investment Officer and Founder at Casdin CapitalBeccaInvestor at Sanofi VenturesGeoffrey SmithFounder / Managing Partner at Digitalis Ventures

+ 8 more

Colleagues at Cure Ventures

Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures

Network3

Bill Amsbaugh
CTO and Partner at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Drew King
CFO and Partner at Cure Ventures

Investors connected to May in public investor directories — a warm-intro map.